Biomedical Engineering Reference
In-Depth Information
Feng SS, Zeng W, Teng Lim Y, et al. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid)
nanoparticles for cardiovascular restenosis treatment. Nanomed 2007;2:333-44.
Fishbein I, Alferiev IS, Nyanguile O, et al. Bisphosphonate-mediated gene vector delivery from
the metal surfaces of stents. PNAS 2006;103:159-164.
Friedrich GJ, Bonatti J. Hybrid coronary artery revascularization - review and update 2007. Heart
Surg Forum 2007;10:E292-6.
Fujii K, Mintz GS, Kobayashi Y, et al. Contribution of stent underexpansion to recurrence after
sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004;109:1085-8.
Halkin A, Stone GW. Polymer-based paclitaxel-eluting stents in percutaneous coronary interven-
tion: a review of the TAXUS trials. J Interv Cardiol 2004;17:271-82.
Hannan EL, Wu C, Walford G, et al. Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting in
Multivessel Coronary Disease. NEJM 2008;358:331-341.
Hofma SH, van der Giessen WJ, van Dalen BM, et al. Indication of long-term endothelial dys-
function after sirolimus-eluting stent implantation. Eur Heart J 2005;27:166-70.
Holmes DR Jr, Teirstein P, Satler L, et al. Sirolimus-eluting stents vs vascular brachytherapy for
in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 2006;295:
1264-73.
Hwang CW, Levin AD, Jonas M, et al. Thrombosis modulates arterial drug distribution for drug-
eluting stents. Circulation 2005;111:1619-26.
Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after
successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.
Iijima R, Mehilli J, Schomig A, Kastrati A. Clinical evidence on polymer-based sirolimus and
paclitaxel eluting stents. Minerva Cardioangiol 2006;54:539-55.
Jabara R, Chronos N, Tondato F, et al. Toxic vessel reaction to an absorbable polymer-based
paclitaxel-eluting stent in pig coronary arteries. J Invasive Cardiol 2006;18:383-90.
Jabs A, Gobel S, Wenzel P, et al. Sirolimus-induced vascular dysfunction: increased mitochondrial
and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production
and decreased vascular nitric oxide formation. J Am Coll Cardiol 2008;51:2130-38.
Jain KK. Nanbiotechnology: applications, markets and companies. Jain PharmaBiotech, Basel,
2011a.
Jain KK. Nitric Oxide: therapeutics, markets & companies. Jain PharmaBiotech, Basel, 2011b.
James SK, Stenestrand U, Lindbäck J, et al. Long-Term Safety and Efficacy of Drug-Eluting
versus Bare-Metal Stents in Sweden. NEJM 2009;360:1933-45.
Jensen J, Lagerqvist B, Aasa M, et al. Clinical and angiographic follow-up after coronary drug-
eluting and bare metal stent implantation. Do drug-eluting stents hold the promise? Journal of
Internal Medicine 2006;260:118-124.
Jeong YH, Hong MK, Lee CW, et al. Impact of significant chronic kidney disease on long-term
clinical outcomes after drug-eluting stent versus bare metal stent implantation. Int J Cardiol
2008;125:36-40.
Johnson TW, Wu YX, Herdeg C, et al. Stent-based delivery of tissue inhibitor of metalloprotei-
nase-3 adenovirus inhibits neointimal formation in porcine coronary arteries. Arterioscler
Thromb Vasc Biol 2005;25:754-9.
Jun HW, Taite LJ, West JL. Nitric oxide-producing polyurethanes. Biomacromolecules.
2005;6:838-44.
Kaiser C, Brunner-La Rocca HP, Buser PT, et al. Incremental cost-effectiveness of drug-eluting
stents compared with a third-generation bare-metal stent in a real-world setting: randomised
Basel Stent Kosten Effektivitäts Trial (BASKET). Lancet 2005; 366:921-929.
Kaiser C, Galatius S, Erne P, et al. Drug-Eluting versus Bare-Metal Stents in Large Coronary
Arteries. NEJM 2010;363:2310-9.
Kaul S, Shah PK, Diamond GA. As time goes by: current status and future directions in the con-
troversy over stenting. J Am Coll Cardiol 2007;50:128-37.
Kim YH, Park SW, Lee CW, et al. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent,
and bare metal stent in the treatment of long coronary lesions. Catheter Cardiovasc Interv
2006;67:181-7.
Search WWH ::
Custom Search